Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
Authors
Keywords
Breast cancer, Ductal carcinoma in situ, Invasive ductal carcinoma, Invasive lobular carcinoma, Invasive mucinous carcinoma, Lobular carcinoma in situ, EpCAM, Ep-ICD and EpEx
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-29
DOI
10.1186/1471-2407-14-726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of EpCAMMFand EpCAMMTvariants in human carcinomas
- (2014) Dominic Fong et al. JOURNAL OF CLINICAL PATHOLOGY
- Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
- (2014) Jung Ho Kim et al. Korean Journal of Pathology
- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
- (2013) H. A. Azim et al. ANNALS OF ONCOLOGY
- EpCAM associates with endoplasmic reticulum aminopeptidase 2 (ERAP2) in breast cancer cells
- (2013) Salah-Eldin Gadalla et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like and HER2 intrinsic subtypes of breast cancer
- (2013) S D Soysal et al. BRITISH JOURNAL OF CANCER
- Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
- (2012) M. Schmidt et al. ANNALS OF ONCOLOGY
- Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
- (2012) Agnieszka Martowicz et al. BMC CANCER
- Expression of cell adhesion molecules and prognosis in breast cancer
- (2012) S. Saadatmand et al. BRITISH JOURNAL OF SURGERY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer
- (2012) Siwei Wei et al. Molecular Oncology
- Effects of EpCAM overexpression on human breast cancer cell lines
- (2011) Johanna M Gostner et al. BMC CANCER
- Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study
- (2011) Per-Henrik Zahl et al. LANCET ONCOLOGY
- EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
- (2010) Ranju Ralhan et al. BMC CANCER
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of EpCAM in Uterine Serous Papillary Carcinoma: Implications for EpCAM-Specific Immunotherapy With Human Monoclonal Antibody Adecatumumab (MT201)
- (2010) K. El-Sahwi et al. MOLECULAR CANCER THERAPEUTICS
- Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
- (2010) Ranju Ralhan et al. PLoS One
- Identification of EpCAM as a Molecular Target of Prostate Cancer Stroma
- (2009) Sumana Mukherjee et al. AMERICAN JOURNAL OF PATHOLOGY
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases
- (2009) Ashley Cimino et al. BREAST CANCER RESEARCH AND TREATMENT
- EpCAM: Another Surface-to-Nucleus Missile
- (2009) Graham Carpenter et al. CANCER CELL
- Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion
- (2009) N. V. Sankpal et al. CANCER RESEARCH
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
- (2009) Anthony L.A. Fields et al. JOURNAL OF CLINICAL ONCOLOGY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry
- (2008) Ranju Ralhan et al. MOLECULAR & CELLULAR PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now